Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

IRS-1 Regulation in Insulin Resistance
Molecular Regulation of Muscle Glucose Metabolism in Man, Protocol 4
Status: Enrolling
Updated:  2/17/2012
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
IRS-1 Regulation in Insulin Resistance
Molecular Regulation of Muscle Glucose Metabolism in Man, Protocol 4
Status: Enrolling
Updated: 2/17/2012
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Continuous Glucose Monitoring in Critically Ill Surgical Patients
Continuous Glucose Monitoring in Critically Ill Surgical Patients
Status: Enrolling
Updated:  2/21/2012
Yale-New Haven Hospital
mi
from
New Haven, CT
Continuous Glucose Monitoring in Critically Ill Surgical Patients
Continuous Glucose Monitoring in Critically Ill Surgical Patients
Status: Enrolling
Updated: 2/21/2012
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Dance Dance Revolution (DDR) in Type 2 Diabetes
Dance Dance Revolution (DDR) Exergaming in Adults With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  2/24/2012
Charles Drew University of Medicine and Science
mi
from
Los Angeles, CA
Dance Dance Revolution (DDR) in Type 2 Diabetes
Dance Dance Revolution (DDR) Exergaming in Adults With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 2/24/2012
Charles Drew University of Medicine and Science
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
Status: Enrolling
Updated:  2/24/2012
The University of Texas
mi
from
Bellaire, TX
A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
Status: Enrolling
Updated: 2/24/2012
The University of Texas
mi
from
Bellaire, TX
Click here to add this to my saved trials
Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine
A Phase 1, Open-Label, Single Cohort, Four-period Sequential Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine in Subjects With Type 2 Diabetes Mellitus
Status: Archived
Updated:  3/2/2012
Cetero Research
mi
from
San Antonio, TX
Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine
A Phase 1, Open-Label, Single Cohort, Four-period Sequential Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine in Subjects With Type 2 Diabetes Mellitus
Status: Archived
Updated: 3/2/2012
Cetero Research
mi
from
San Antonio, TX
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
Status: Enrolling
Updated:  3/5/2012
Diabetes Care Center
mi
from
Salinas, CA
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
Status: Enrolling
Updated: 3/5/2012
Diabetes Care Center
mi
from
Salinas, CA
Click here to add this to my saved trials
Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
A Phase 1, Open-label, Single Cohort, Two-Period Fixed Sequence Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg Twice Daily in Subjects With Type 2 Diabetes Mellitus
Status: Archived
Updated:  3/6/2012
SeaView Research Inc.
mi
from
Miami, FL
Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
A Phase 1, Open-label, Single Cohort, Two-Period Fixed Sequence Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg Twice Daily in Subjects With Type 2 Diabetes Mellitus
Status: Archived
Updated: 3/6/2012
SeaView Research Inc.
mi
from
Miami, FL
D Vitamin Intervention in VA
Vitamin D Deficiency and Treatment in Male Veterans at Risk for Diabetes
Status: Enrolling
Updated:  3/7/2012
Jesse Brown VA Medical Center, Chicago, IL
mi
from
Chicago, IL
D Vitamin Intervention in VA
Vitamin D Deficiency and Treatment in Male Veterans at Risk for Diabetes
Status: Enrolling
Updated: 3/7/2012
Jesse Brown VA Medical Center, Chicago, IL
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety Study of Topical Human FGF-1 for Wound Healing
A Phase 1a, Open Label, Single Dose, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Normal Volunteers Given Punch Skin Biopsies
Status: Enrolling
Updated:  3/9/2012
Dedicated Phase I
mi
from
Phoenix, AZ
Safety Study of Topical Human FGF-1 for Wound Healing
A Phase 1a, Open Label, Single Dose, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Normal Volunteers Given Punch Skin Biopsies
Status: Enrolling
Updated: 3/9/2012
Dedicated Phase I
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Insulin Delivery Using Microneedles in Type 1 Diabetes
Insulin Delivery Using Microneedles in Type 1 Diabetes
Status: Enrolling
Updated:  3/19/2012
Emroy University
mi
from
Atlanta, GA
Insulin Delivery Using Microneedles in Type 1 Diabetes
Insulin Delivery Using Microneedles in Type 1 Diabetes
Status: Enrolling
Updated: 3/19/2012
Emroy University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Insulin Secretion in Diabetes
Pathogenesis of the Impaired Incretin Effect in Type 2 Diabetes
Status: Enrolling
Updated:  3/20/2012
VA Medical Center, Cincinnati
mi
from
Cincinnati, OH
Insulin Secretion in Diabetes
Pathogenesis of the Impaired Incretin Effect in Type 2 Diabetes
Status: Enrolling
Updated: 3/20/2012
VA Medical Center, Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Status: Enrolling
Updated:  3/21/2012
Ohio State University
mi
from
Columbus, OH
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Status: Enrolling
Updated: 3/21/2012
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes
Status: Enrolling
Updated:  3/21/2012
Ohio State University
mi
from
Columbus, OH
Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes
Status: Enrolling
Updated: 3/21/2012
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Agave Clinical Research
mi
from
Tempe, AZ
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Agave Clinical Research
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Harrisburg Family Medical Center
mi
from
Harrisburg, AR
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Harrisburg Family Medical Center
mi
from
Harrisburg, AR
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Arkansas Primary Care Clinic, P.A.
mi
from
Little Rock, AR
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Arkansas Primary Care Clinic, P.A.
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Providence Clinical Research
mi
from
San Fernando Valley, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Providence Clinical Research
mi
from
San Fernando Valley, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Sc Clinical Research, Inc.
mi
from
Garden Grove, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Sc Clinical Research, Inc.
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Premiere Clinical Research
mi
from
Lakewood, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Premiere Clinical Research
mi
from
Lakewood, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Long Beach Center for Clinical Research
mi
from
Long Beach,, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Long Beach Center for Clinical Research
mi
from
Long Beach,, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
UCLA Kidney Transplant Research
mi
from
Los Angelas, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
UCLA Kidney Transplant Research
mi
from
Los Angelas, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
David Geffen School of Medicine Division of Nephrology
mi
from
Los Angelas, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
David Geffen School of Medicine Division of Nephrology
mi
from
Los Angelas, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Desert Oasis Healthcare Medical Group
mi
from
Palm Springs, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Desert Oasis Healthcare Medical Group
mi
from
Palm Springs, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Apex Research of Riverside
mi
from
Riverside, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Apex Research of Riverside
mi
from
Riverside, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
River City Clinical Research
mi
from
Sacramento, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
River City Clinical Research
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Samsun Clinic
mi
from
Santa Barbara, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Samsun Clinic
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Orange County Research Center
mi
from
Tustin, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Infosphere Clinical Research, Inc.
mi
from
West Hills, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Infosphere Clinical Research, Inc.
mi
from
West Hills, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Creekside Endocrine Associates PC
mi
from
Denver, CO
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Creekside Endocrine Associates PC
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Palm Spring Research Institute
mi
from
Hialeah, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Palm Spring Research Institute
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
San Marcus Research Clinic
mi
from
Miami, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
San Marcus Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Advanced Pharma CR
mi
from
Kendall Lakes-Lindgren Acres, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Advanced Pharma CR
mi
from
Kendall Lakes-Lindgren Acres, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Ormond Medical Arts Pharmaceutical Research
mi
from
Ormond Beach, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Ormond Medical Arts Pharmaceutical Research
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Clincal Research of Central Florida
mi
from
Winter Haven, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clincal Research of Central Florida
mi
from
Winter Haven, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
River Birch Research Alliance
mi
from
Blue Ridge, GA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
River Birch Research Alliance
mi
from
Blue Ridge, GA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Apex Medical Research
mi
from
Chicago, IL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Apex Medical Research
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
University of Chicago Medical Center
mi
from
Chicago, IL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
American Health Network of IN
mi
from
Avon, IN
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
American Health Network of IN
mi
from
Avon, IN
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
American Healthcare Network of Indiana
mi
from
Greenfield, IN
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
American Healthcare Network of Indiana
mi
from
Greenfield, IN
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Medstar Health Research Institute
mi
from
Hyattsville, MD
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Medstar Health Research Institute
mi
from
Hyattsville, MD
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Brigham and Women's Hosp
mi
from
Boston, MA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Harvard Medical School Beth Israel Deaconess Medical Center
mi
from
Boston, MA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Harvard Medical School Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Apex Medical Research, MI, Inc.
mi
from
Flint, MI
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Apex Medical Research, MI, Inc.
mi
from
Flint, MI
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Clinical Research Consultants (MO)
mi
from
Kansas City, MO
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clinical Research Consultants (MO)
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
The Rogosin Institute
mi
from
, NY
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
The Rogosin Institute
mi
from
, NY
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Clinical Research Development Associates (NY)
mi
from
Rosedale, NY
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clinical Research Development Associates (NY)
mi
from
Rosedale, NY
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Clinical Research Limited
mi
from
Canton, OH
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clinical Research Limited
mi
from
Canton, OH
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Lynn Institute of Norman
mi
from
Norman, OK
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Lynn Institute of Norman
mi
from
Norman, OK
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
C.S.R.A. Renal Services
mi
from
Aiken, SC
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
C.S.R.A. Renal Services
mi
from
Aiken, SC
Click here to add this to my saved trials